#MESX0000036POrdinance for the Legislative Part of the Public Health Code
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
This law restructures and codifies the legislative part of France's public health code. It simplifies and updates a previously fragmented legal framework affecting health care rights, bioethics, health safety, and more, by organizing the laws into a comprehensive code. The changes will impact healthcare professionals, institutions, and administrative bodies by providing clearer legal guidelines and updated regulations.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Reorganizes public health law into a comprehensive code.
- Simplifies legislative framework to clarify healthcare rights.
- Updates laws for modern bioethics and health safety concerns.
Obligations
What this law requires
Healthcare professionals and institutions must comply with the reorganized Public Health Code structure, which consolidates legislative provisions previously scattered across multiple decrees and laws into a unified code with 6 main parts covering general health protection, family health, disease control, health professions, health products, and health establishments.
Health establishments, medical laboratories, and medical transport services must operate under the updated regulatory framework defined in Part VI of the new code, which consolidates and updates applicable provisions for health establishments, cancer treatment centers, medical biology analysis laboratories, and medical transport services.
All health professions (medical professionals, pharmacists, pharmacy technicians, and medical auxiliaries) must comply with updated conditions for legal exercise of their profession, including definitions, legal requirements, authorized exceptions, and penalties for illegal practice and title usurpation as codified in Part IV.
Health product manufacturers and distributors must comply with updated regulations governing medications (human and veterinary use), related products, medical devices, and other health products as defined in Part V, including provisions enforced by the French Health Products Safety Agency.
Healthcare administrators and professionals must ensure patient rights protections as codified in Part I, Book I, including rights to palliative care access (Law 99-477 of June 9, 1999) and other patient protection provisions under development.